RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Clinical Trials

Participating in a clinical trial gives you access to cutting-edge treatments and expert care, while helping advance research that could benefit countless others. You’ll be closely monitored by top physicians throughout the trial to ensure your safety, and if the treatment proves effective, you could be among the first to benefit. Your involvement today helps shape the future of kidney disease care. To learn more about current trials and how to get involved, visit our clinical trial resources.

Find a Clinical Trial That is Right for You

Use our clinical trial matching tool to see if you match to any rare kidney diseases (RKD) clinical trials. Just answer a few quick questions, and we’ll help connect you to trials that may be right for you. Your participation could lead to better treatments and hope for the RKD community.

What is your diagnosis?
Please assume that the conditions listed are "Primary" or Idiopathic". If you have a genetic mutation, we will consider it to be "Primary" for the purposes of the question.
Have you ever had a kidney transplant?
Are you currently on dialysis?
Are you currently spilling protein?
Did you have a biopsy to confirm your diagnosis?
What is your current eGFR?
What was your latest UPCR (urine protein to creatinine ratio)?
What treatments have you taken for your disease?
Are you considered one of the following?
Are you currently on the transplant wait-list?
Disclaimer

The “Am I A Match?” tool is designed solely to help filter the clinical trials listed below based on your responses.

Filter Results By

Download List of

Clinical Trials

Download PDF

Want to Learn More about Clinical Trials?

View Resources

Featured

All Clinical Trials

Download Clinical Trials

Searching for nearby trials...
This may take a moment
NOBLE
The study is evaluating the safety and effectiveness of an investigational, targeted C3 inhibitor called pegcetacoplan in adults who have C3G or IC-MPGN recurrence after...

Currently Enrolling

Interventional

C3 GLOMERULOPATHY

IC-MPGN

Adult

VALIANT
The purpose of this study is to assess the efficacy and safety of twice weekly pegcetacoplan compared to placebo in patients with C3G or IC-MPGN, on the basis of a reduction...

Currently Enrolling

Interventional

C3 GLOMERULOPATHY

IC-MPGN

CARE and JUSTICE
JUSTICE is a single-center, double-blinded, randomized trial of baricitinib therapy for APOL1-associated FSGS or Hypertension Associated-CKD.

Currently Enrolling

Interventional

FSGS

ASSIST
A study to learn if atrasentan is safe and works in people with IgA nephropathy who are taking an SGLT2 inhibitor.

Currently Enrolling

Interventional

FSGS

IgA NEPHROPATHY

CureGN
Cure Glomerulonephropathy (CureGN) is a multicenter five-year observational study of glomerular disease patients.

Currently Enrolling

Observational

C3 GLOMERULOPATHY

FSGS

IC-MPGN

IgA NEPHROPATHY

MEMBRANOUS NEPHROPATHY

MINIMAL CHANGE DISEASE

NEPHROTIC SYNDROME

Headline decoration line

Careers

Explore career opportunities at NephCure, where passion meets purpose. Our dedicated team is committed to advancing research, supporting patients, and raising awareness for rare kidney diseases. Explore rewarding career opportunities today.

JOIN THE TEAM

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.